NTU Studies in Language and Literature, ISSN 1018-3914, 2016, Volume 36, p. 71
Journal Article
Dermatologic Therapy, ISSN 1396-0296, 11/2019, Volume 32, Issue 6, p. n/a
Journal Article
Medical Care, ISSN 0025-7079, 01/2019, Volume 57, Issue 1, pp. 28 - 35
BACKGROUND:To enhance the quality of hospice care and to facilitate consumers’ choices, the Centers for Medicare and Medicaid Services (CMS) began the Hospice...
Journal Article
Journal of Business Ethics, ISSN 0167-4544, 10/2017, Volume 145, Issue 3, pp. 563 - 575
This study examines whether truth-telling in the form of honest reporting is associated with cognitive moral development. Conventional agency theory assumes...
Defining Issues Test | Ethics | Ethical behavior | Business Ethics | Managerial reward schemes | Quality of Life Research | Management | Business and Management, general | Philosophy | Agency theory | SCREENING ETHICS | SITUATION | BUSINESS | MODEL | EDUCATION | INTENTIONS | UNETHICAL BEHAVIOR | DECISION-MAKING | PREFERENCES | PROPENSITY | INFORMATION-SYSTEMS | ETHICS | Managers | Analysis | Business schools | Profitability | Deception | Profits | Cognition | Management reports | Auditing | Development programs | Studies | Social psychology | Honesty | Morality | Principal-agent models | Rewards | Reputation | Moral development | Truth | Business ethics
Defining Issues Test | Ethics | Ethical behavior | Business Ethics | Managerial reward schemes | Quality of Life Research | Management | Business and Management, general | Philosophy | Agency theory | SCREENING ETHICS | SITUATION | BUSINESS | MODEL | EDUCATION | INTENTIONS | UNETHICAL BEHAVIOR | DECISION-MAKING | PREFERENCES | PROPENSITY | INFORMATION-SYSTEMS | ETHICS | Managers | Analysis | Business schools | Profitability | Deception | Profits | Cognition | Management reports | Auditing | Development programs | Studies | Social psychology | Honesty | Morality | Principal-agent models | Rewards | Reputation | Moral development | Truth | Business ethics
Journal Article
Journal of the American Chemical Society, ISSN 0002-7863, 10/2008, Volume 130, Issue 43, pp. 14129 - 14138
The glycerophosphodiesterase (GpdQ) from Enterobacter aerogenes is a promiscuous binuclear metallohydrolase that catalyzes the hydrolysis of mono-, di-, and...
PURPLE ACID-PHOSPHATASE | TRANSITION-STATE STRUCTURES | SER/THR PROTEIN PHOSPHATASE | DNA-POLYMERASE-I | X-RAY-STRUCTURE | ESCHERICHIA-COLI | P-NITROPHENYL PHOSPHATE | MAGNETIC CIRCULAR-DICHROISM | PHOSPHORYL-TRANSFER REACTIONS | CHEMISTRY, MULTIDISCIPLINARY | SITE METAL-IONS | Enterobacter aerogenes - enzymology | Mutagenesis, Site-Directed | Models, Molecular | Phosphoric Diester Hydrolases - drug effects | Crystallography, X-Ray | Phosphoric Diester Hydrolases - genetics | Structure-Activity Relationship | Enzyme Activation - drug effects | Magnetics | Phosphoric Diester Hydrolases - chemistry | Dose-Response Relationship, Drug | Hydrolysis | Cobalt - pharmacology | Esters - chemistry | Potassium Compounds - pharmacology | Molecular Structure | Catalysis | Kinetics | Binding Sites | Circular Dichroism | Phosphates - pharmacology | Hydrogen-Ion Concentration | Glycerin | Enterobacter | Analysis | Physiological aspects | Glycerol | Chemical properties | Phosphodiesterases | Enterobacteriaceae | Index Medicus | Binuclear metallohydrolases | catalysis | glycerophosphodiesterase | metal ion binding | enzyme regulation
PURPLE ACID-PHOSPHATASE | TRANSITION-STATE STRUCTURES | SER/THR PROTEIN PHOSPHATASE | DNA-POLYMERASE-I | X-RAY-STRUCTURE | ESCHERICHIA-COLI | P-NITROPHENYL PHOSPHATE | MAGNETIC CIRCULAR-DICHROISM | PHOSPHORYL-TRANSFER REACTIONS | CHEMISTRY, MULTIDISCIPLINARY | SITE METAL-IONS | Enterobacter aerogenes - enzymology | Mutagenesis, Site-Directed | Models, Molecular | Phosphoric Diester Hydrolases - drug effects | Crystallography, X-Ray | Phosphoric Diester Hydrolases - genetics | Structure-Activity Relationship | Enzyme Activation - drug effects | Magnetics | Phosphoric Diester Hydrolases - chemistry | Dose-Response Relationship, Drug | Hydrolysis | Cobalt - pharmacology | Esters - chemistry | Potassium Compounds - pharmacology | Molecular Structure | Catalysis | Kinetics | Binding Sites | Circular Dichroism | Phosphates - pharmacology | Hydrogen-Ion Concentration | Glycerin | Enterobacter | Analysis | Physiological aspects | Glycerol | Chemical properties | Phosphodiesterases | Enterobacteriaceae | Index Medicus | Binuclear metallohydrolases | catalysis | glycerophosphodiesterase | metal ion binding | enzyme regulation
Journal Article
Molecular Biology and Evolution, ISSN 0737-4038, 09/2013, Volume 30, Issue 9, pp. 2001 - 2012
Many enzymes exhibit some catalytic promiscuity or substrate ambiguity. These weak activities do not affect the fitness of the organism under ordinary...
substrate ambiguity | substrate specificity | catalytic promiscuity | directed evolution | PERSPECTIVE | BENEFICIAL MUTATIONS | DIMINISHING RETURNS | BIOCHEMISTRY & MOLECULAR BIOLOGY | ENZYMATIC-ACTIVITIES | EPISTASIS | HIGH-EFFICIENCY TRANSFORMATION | EVOLUTIONARY BIOLOGY | REACTION PATHWAY | GENETICS & HEREDITY | DEHALOGENASE | PHOSPHOSERINE PHOSPHATASE | Phosphoric Monoester Hydrolases - genetics | Proteome - genetics | Biocatalysis | Escherichia coli - enzymology | Genes, Suppressor | Models, Molecular | Substrate Specificity | Escherichia coli Proteins - metabolism | Phosphoserine - metabolism | Genetic Complementation Test | Histidinol-Phosphatase - genetics | Biological Evolution | Histidinol-Phosphatase - metabolism | Epistasis, Genetic | Escherichia coli - genetics | Escherichia coli Proteins - genetics | Kinetics | Mutation | Gene Expression Regulation, Bacterial | Phosphoric Monoester Hydrolases - metabolism | Proteome - metabolism | Fast Tracks
substrate ambiguity | substrate specificity | catalytic promiscuity | directed evolution | PERSPECTIVE | BENEFICIAL MUTATIONS | DIMINISHING RETURNS | BIOCHEMISTRY & MOLECULAR BIOLOGY | ENZYMATIC-ACTIVITIES | EPISTASIS | HIGH-EFFICIENCY TRANSFORMATION | EVOLUTIONARY BIOLOGY | REACTION PATHWAY | GENETICS & HEREDITY | DEHALOGENASE | PHOSPHOSERINE PHOSPHATASE | Phosphoric Monoester Hydrolases - genetics | Proteome - genetics | Biocatalysis | Escherichia coli - enzymology | Genes, Suppressor | Models, Molecular | Substrate Specificity | Escherichia coli Proteins - metabolism | Phosphoserine - metabolism | Genetic Complementation Test | Histidinol-Phosphatase - genetics | Biological Evolution | Histidinol-Phosphatase - metabolism | Epistasis, Genetic | Escherichia coli - genetics | Escherichia coli Proteins - genetics | Kinetics | Mutation | Gene Expression Regulation, Bacterial | Phosphoric Monoester Hydrolases - metabolism | Proteome - metabolism | Fast Tracks
Journal Article
Dermatology Online Journal, ISSN 1087-2108, 2016, Volume 22, Issue 4
Fixed drug eruption (FDE) is a type of cutaneous drug reaction that occurs at the same sites upon re-exposure to specific medications. Herein we discuss the...
Young Adult | Drug Eruptions - etiology | Antifungal Agents - adverse effects | Humans | Tinea Versicolor - drug therapy | Axilla | Fluconazole - adverse effects | Male | Facial Dermatoses - chemically induced
Young Adult | Drug Eruptions - etiology | Antifungal Agents - adverse effects | Humans | Tinea Versicolor - drug therapy | Axilla | Fluconazole - adverse effects | Male | Facial Dermatoses - chemically induced
Journal Article
JAMA Dermatology, ISSN 2168-6068, 01/2019, Volume 155, Issue 1, pp. 121 - 122
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2017, Volume 76, Issue 6, pp. e221 - e221
Journal Article
Respiratory Medicine, ISSN 0954-6111, 2013, Volume 107, Issue 6, pp. 911 - 918
Summary Introduction Lung cancer is a leading cause of cancer mortality worldwide. Non-invasively collected biofluids such as exhaled breath condensate (EBC)...
Pulmonary/Respiratory | Breath condensate | Breath test | Mitochondrial DNA | D-loop | Lung cancer | Non-small cell lung cancer | APOPTOSIS | OXIDATIVE STRESS | CARDIAC & CARDIOVASCULAR SYSTEMS | HETEROPLASMY | TISSUE | MARKERS | SMOKING | GENOME | REGION | REPLICATION | RESPIRATORY SYSTEM | PROGRESSION | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Cross-Sectional Studies | Carcinoma, Non-Small-Cell Lung - genetics | Humans | Middle Aged | Breath Tests | Lung Neoplasms - pathology | Male | Smoking - genetics | DNA Mutational Analysis - methods | DNA, Mitochondrial - genetics | Saliva - metabolism | Female | Aged | DNA, Neoplasm - genetics | Mutation | Neoplasm Staging | Cancer patients | Gene mutations | Mortality | Genetic research | Genetic aspects | Cancer | Studies | Design | Biomedical research | Biomarkers | Thermal cycling | Deoxyribonucleic acid--DNA | Tumors | Index Medicus
Pulmonary/Respiratory | Breath condensate | Breath test | Mitochondrial DNA | D-loop | Lung cancer | Non-small cell lung cancer | APOPTOSIS | OXIDATIVE STRESS | CARDIAC & CARDIOVASCULAR SYSTEMS | HETEROPLASMY | TISSUE | MARKERS | SMOKING | GENOME | REGION | REPLICATION | RESPIRATORY SYSTEM | PROGRESSION | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Cross-Sectional Studies | Carcinoma, Non-Small-Cell Lung - genetics | Humans | Middle Aged | Breath Tests | Lung Neoplasms - pathology | Male | Smoking - genetics | DNA Mutational Analysis - methods | DNA, Mitochondrial - genetics | Saliva - metabolism | Female | Aged | DNA, Neoplasm - genetics | Mutation | Neoplasm Staging | Cancer patients | Gene mutations | Mortality | Genetic research | Genetic aspects | Cancer | Studies | Design | Biomedical research | Biomarkers | Thermal cycling | Deoxyribonucleic acid--DNA | Tumors | Index Medicus
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2013, Volume 70, Issue 1, pp. 168 - 177
Background Many studies have identified cardiovascular risk factors in patients with psoriasis. Some psoriasis therapies may increase cardiovascular disease...
Dermatology | cyclosporine | psoralen plus ultraviolet A | ultraviolet therapy | ustekinumab | biologic therapies | etanercept | infliximab | psoriasis | methotrexate | mycophenolate mofetil | cardiovascular | adalimumab | MODIFYING ANTIRHEUMATIC DRUGS | IMPROVES ENDOTHELIAL FUNCTION | CAUSE-SPECIFIC MORTALITY | ANTI-TNF THERAPY | FACTOR-ALPHA BLOCKADE | NECROSIS-FACTOR ANTAGONISTS | NARROW-BAND UVB | DERMATOLOGY | LONG-TERM SAFETY | RHEUMATOLOGY-BIOLOGICS-REGISTER | CORONARY-HEART-DISEASE | PUVA Therapy - adverse effects | Antibodies, Monoclonal, Humanized - adverse effects | Cardiovascular Diseases - etiology | Psoriasis - drug therapy | Humans | Keratolytic Agents - adverse effects | Ustekinumab | Methotrexate - adverse effects | Mycophenolic Acid - adverse effects | Mycophenolic Acid - analogs & derivatives | Biological Therapy - adverse effects | Cyclosporine - adverse effects | Immunosuppressive Agents - adverse effects | Cardiovascular Diseases - chemically induced | Acitretin - adverse effects | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Psoriasis - therapy | Medical colleges | Care and treatment | Psoriasis | Cardiac patients | Formulae, receipts, prescriptions | Dermatologic agents | Cardiovascular diseases | Risk factors
Dermatology | cyclosporine | psoralen plus ultraviolet A | ultraviolet therapy | ustekinumab | biologic therapies | etanercept | infliximab | psoriasis | methotrexate | mycophenolate mofetil | cardiovascular | adalimumab | MODIFYING ANTIRHEUMATIC DRUGS | IMPROVES ENDOTHELIAL FUNCTION | CAUSE-SPECIFIC MORTALITY | ANTI-TNF THERAPY | FACTOR-ALPHA BLOCKADE | NECROSIS-FACTOR ANTAGONISTS | NARROW-BAND UVB | DERMATOLOGY | LONG-TERM SAFETY | RHEUMATOLOGY-BIOLOGICS-REGISTER | CORONARY-HEART-DISEASE | PUVA Therapy - adverse effects | Antibodies, Monoclonal, Humanized - adverse effects | Cardiovascular Diseases - etiology | Psoriasis - drug therapy | Humans | Keratolytic Agents - adverse effects | Ustekinumab | Methotrexate - adverse effects | Mycophenolic Acid - adverse effects | Mycophenolic Acid - analogs & derivatives | Biological Therapy - adverse effects | Cyclosporine - adverse effects | Immunosuppressive Agents - adverse effects | Cardiovascular Diseases - chemically induced | Acitretin - adverse effects | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Psoriasis - therapy | Medical colleges | Care and treatment | Psoriasis | Cardiac patients | Formulae, receipts, prescriptions | Dermatologic agents | Cardiovascular diseases | Risk factors
Journal Article
Canadian Journal of Administrative Sciences / Revue Canadienne des Sciences de l'Administration, ISSN 0825-0383, 03/2019, Volume 36, Issue 1, pp. 128 - 144
Journal Article
Nature Genetics, ISSN 1061-4036, 04/2018, Volume 50, Issue 4, pp. 524 - 537
Stroke has multiple etiologies, but the underlying genes and pathways are largely unknown. We conducted a multiancestry genome-wide-association meta-analysis...
HUMAN GENETIC-VARIATION | SMALL-VESSEL DISEASE | SUDDEN CARDIAC DEATH | SUSCEPTIBILITY LOCI | WHITE-MATTER HYPERINTENSITIES | ISCHEMIC-STROKE | COMPLEX TRAITS | CORONARY-ARTERY-DISEASE | HEMORRHAGIC STROKE | ATRIAL-FIBRILLATION | GENETIC-VARIATION | RARE VARIANTS | HTRA1 MUTATIONS | CANDIDATE GENES | GENETICS & HEREDITY | BLOOD-PRESSURE | Stroke | Genes | Health risks | Risk | Cardiovascular disease | Genomes | Genetic diversity | Regression analysis | Loci | Meta-analysis | Consortia | Pleiotropy | Etiology | Blood pressure | Thromboembolism | Bioinformatics | Asians | Basic Medicine | Medical Genetics | Medicinsk genetik | Medical and Health Sciences | Medicin och hälsovetenskap | Medicinska och farmaceutiska grundvetenskaper
HUMAN GENETIC-VARIATION | SMALL-VESSEL DISEASE | SUDDEN CARDIAC DEATH | SUSCEPTIBILITY LOCI | WHITE-MATTER HYPERINTENSITIES | ISCHEMIC-STROKE | COMPLEX TRAITS | CORONARY-ARTERY-DISEASE | HEMORRHAGIC STROKE | ATRIAL-FIBRILLATION | GENETIC-VARIATION | RARE VARIANTS | HTRA1 MUTATIONS | CANDIDATE GENES | GENETICS & HEREDITY | BLOOD-PRESSURE | Stroke | Genes | Health risks | Risk | Cardiovascular disease | Genomes | Genetic diversity | Regression analysis | Loci | Meta-analysis | Consortia | Pleiotropy | Etiology | Blood pressure | Thromboembolism | Bioinformatics | Asians | Basic Medicine | Medical Genetics | Medicinsk genetik | Medical and Health Sciences | Medicin och hälsovetenskap | Medicinska och farmaceutiska grundvetenskaper
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2016, Volume 75, Issue 4, pp. e169 - e169
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2011, Volume 67, Issue 2, pp. 279 - 288
Background A task force of the National Psoriasis Foundation Medical Board was convened to evaluate treatment options for pustular psoriasis. Meetings were...
Dermatology | psoriasis | drug therapy | ULTRAVIOLET-B PHOTOTHERAPY | LONG-TERM | PALMOPLANTAR PUSTULOSIS | FOLLOW-UP | DERMATOLOGY | BETAMETHASONE DIPROPIONATE | ACRODERMATITIS CONTINUA | RECALCITRANT PSORIASIS | LOW-DOSE CYCLOSPORINE | CASE SERIES | ACID PHOTODYNAMIC THERAPY | PUVA Therapy - methods | Psoriasis - drug therapy | Societies, Medical | Photosensitizing Agents - therapeutic use | Humans | Specialty Boards | Ficusin - therapeutic use | Medical colleges | Care and treatment | Task forces | Psoriasis | Formulae, receipts, prescriptions | Coumarins | Dermatologic agents | Drug therapy | Index Medicus
Dermatology | psoriasis | drug therapy | ULTRAVIOLET-B PHOTOTHERAPY | LONG-TERM | PALMOPLANTAR PUSTULOSIS | FOLLOW-UP | DERMATOLOGY | BETAMETHASONE DIPROPIONATE | ACRODERMATITIS CONTINUA | RECALCITRANT PSORIASIS | LOW-DOSE CYCLOSPORINE | CASE SERIES | ACID PHOTODYNAMIC THERAPY | PUVA Therapy - methods | Psoriasis - drug therapy | Societies, Medical | Photosensitizing Agents - therapeutic use | Humans | Specialty Boards | Ficusin - therapeutic use | Medical colleges | Care and treatment | Task forces | Psoriasis | Formulae, receipts, prescriptions | Coumarins | Dermatologic agents | Drug therapy | Index Medicus
Journal Article